PRECLINICAL RESULTS OF GEOVAX’S AIDS VACCINES DEMONSTRATE POTENTIAL TO PROTECT AGAINST DISEASE

GeoVax Labs, Inc., an Atlanta-based biotechnology association, currently reported successful formula from a preclinical hearing regulating GeoVax’s vaccines for a healing diagnosis as well as impediment of Acquired Immunodeficiency Disease Syndrome( “AIDS”) in non-human primates. A interpretation denote a efficacy of GeoVax’s /MVA vaccines in determining a Simian( “SIV”) AIDS pathogen by defence responses lifted by a vaccines. These earnest formula have resulted in rough skeleton to control tellurian healing studies utilizing GeoVax’s vaccines.

Tags: ,

Related posts

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.